Cargando…
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
INTRODUCTION: The purpose of this study is to investigate the effects of agomelatine on anxious symptoms and functional impairment in a pooled dataset from randomized placebo-controlled trials for generalized anxiety disorder (GAD). METHODS: Data from three randomized, placebo-controlled trials that...
Autores principales: | Stein, Dan J., Khoo, Jon-Paul, Picarel-Blanchot, Françoise, Olivier, Valérie, Van Ameringen, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932987/ https://www.ncbi.nlm.nih.gov/pubmed/33537871 http://dx.doi.org/10.1007/s12325-020-01583-9 |
Ejemplares similares
-
The safety of agomelatine in standard medical practice in depressed patients: A 26‐week international multicentre cohort study
por: Gorwood, Philip, et al.
Publicado: (2020) -
Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France
por: Gorwood, Philip, et al.
Publicado: (2020) -
Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021) -
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023) -
Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)